SCHEMBL1003235

SCHEMBL1003235

CC1(C)OC=C(O)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921452 0.78
SCHEMBL3673897 0.78
SCHEMBL9404445 0.73 SIGMAR1 (0.33)
SCHEMBL22715989 0.65
SCHEMBL2318962 0.57 ALDH1A1 (0.42)
SCHEMBL9789733 0.56 LMNA (0.39)
SCHEMBL15388350 0.55
SCHEMBL5316374 0.55
SCHEMBL7637933 0.54
SCHEMBL11579611 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011011065-A1 METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE MOAZED KAMBIZ THOMAS (US) 2011-01-27 WO claimed
US-20040180829-A1 Compounds and methods for regulating bacterial growth and pathogenesis QUOREX PHARMACEUTICALS, INC. 2004-09-16 US claimed
US-20040097402-A1 COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS NATIONAL SCIENCE FOUNDATION 2004-05-20 US claimed
EP-1282415-A2 COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS Princeton University Office of Techology Licensing & I.P. (US) 2003-02-12 EP claimed
WO-2001085664-A2 COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS PRINCETON UNIVERSITY (US) 2001-11-15 WO claimed
EP-0398417-A1 Hydroxyfuranone preparation QUEST INTERNATIONAL B.V. (NL) 1990-11-22 EP claimed
CN-117683006-B Preparation method of 2, 5-dimethyl-4-hydroxy-3 (2H) -furanone 济南悟通生物科技有限公司 2024-04-16 CN disclosed
CN-117683006-A Preparation method of 2, 5-dimethyl-4-hydroxy-3 (2H) -furanone 济南悟通生物科技有限公司 2024-03-12 CN disclosed
WO-2023276505-A1 FLAVOR IMPARTING COMPOSITION INCLUDING DISULFIDE COMPOUND 長谷川香料株式会社 2023-01-05 WO disclosed
WO-2022085379-A1 LACTONE COMPOUND 長谷川香料株式会社 2022-04-28 WO disclosed
US-20200037646-A1 Flavor Modifiers For Meat Analog Products GIVAUDAN SA (CH) 2020-02-06 US disclosed
EP-3558508-A1 MICROCAPSULES Symrise AG (DE) 2019-10-30 EP disclosed
US-20130196934-A1 COMPOSITION FOR PERINATAL AND NEONATAL STROKE PAUL BRADLEY ADDIS, PH.D. 2013-08-01 US disclosed
WO-2010087983-A1 METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE MOAZED KAMBIZ THOMAS (US) 2010-08-05 WO disclosed
CN-1937930-A Palatability enhanced composition and method for animal consumption HILLS PET NUTRITION INC (US) 2007-03-28 CN disclosed
US-5046514-A Sugar coated cellulosic substrate; cigarettes IMPERIAL TOBACCO LIMITED (GB) 1991-09-10 US disclosed
EP-0398417-A1 Hydroxyfuranone preparation QUEST INTERNATIONAL B.V. (NL) 1990-11-22 EP disclosed
EP-0364819-A2 LHRH analogs The Administrators of The Tulane Educational Fund (US) 1990-04-25 EP disclosed
EP-0317033-A1 A process for preparing L-rhamnose UNILEVER N.V. (NL) 1989-05-24 EP disclosed
EP-0286256-A2 Smoking material and process for making same IMPERIAL TOBACCO LIMITED (GB) 1988-10-12 EP disclosed